
@EASLedu brings you the latest on #liver research & education. Visit #EASLCampus ----------------- EASL does not express any political opinion. RT ≠ endorsement
Joined January 2016
- Tweets19.9K
- Following721
- Followers13.9K
- Likes10.6K
Pinned Tweet
🧠 This week's #TalkLiverToMe explores the complex interplay between liver health, the brain, addiction and mental health. Well worth a listen!
More info below👇👇
@IsraelsenMads @vtkronsten @FLASH_OUH @OUHhospital @MaudsleyNHS
#LiverX #TalkLiverToMe
New episode out! Tune in #TalkLivertoMe for a discussion on psychohepatology, the gut–liver–brain axis, addiction biology, trauma, PTSD, and integrated approaches to care.
Listen now on EASL Campus: easlcampus.eu/tltm/episode-1…
Also on Spotify and Apple Podcasts!
Host an EASL School in 2028: easl.eu/what-we-do/education…
EASL Education retweeted
#Baveno VIII consensus in portal hypertension #CSPH
Full Consensus Report now @JHepatology @EASLnews
journal-of-hepatology.eu/art…
New episode out! Tune in #TalkLivertoMe for a discussion on psychohepatology, the gut–liver–brain axis, addiction biology, trauma, PTSD, and integrated approaches to care.
Listen now on EASL Campus: easlcampus.eu/tltm/episode-1…
Also on Spotify and Apple Podcasts!
Host an EASL School in 2028: easl.eu/what-we-do/education…
Don't miss #TalkLiverToMe this Wednesday!!
@IsraelsenMads @vtkronsten @FLASH_OUH @OUHhospital @MaudsleyNHS
#LiverX
Are we overlooking mental health in liver disease care?
In this episode of #TalkLivertoMe we explore psychohepatology, from the gut–liver–brain axis to the links between liver disease, addiction, trauma, depression, and anxiety.
easl.eu/event/psychohepatolo…
Host an EASL School in 2028: easl.eu/what-we-do/education…
#MASLDAcademy Module 2:
Thank you to the organisers and congratulations to all the participants for completing this module👏👏
@FrancqueSven @kvvanten @UZAnieuws
@UAntwerpen
#LiverTwitter
Module 2 of the EASL MASLD Guidelines Academy took place on 8-9 October in Antwerp, Belgium, taking participants on a deeper dive into MASLD.
Expert-led sessions explored MASLD pathophysiology and its links with cardiovascular disease. Clinical cases and interactive workshops also examined the role of liver biopsy and non-invasive tests in clinical practice.
#LiverTwitter #LiverX
🇧🇪 Module 2 of the EASL MASLD Guidelines Academy is underway at UZA – Antwerp University Hospital!
Participants are taking a deeper dive into MASLD pathophysiology, cardiovascular disease, liver biopsy, and non-invasive assessment through expert-led sessions, clinical cases, and interactive workshops.
@UZAnieuws @FrancqueSven @kvvanten
#LiverX #MASLD #MASLDAcademy
The EASL Experimental & Translational Science School: The Spatial Biology of Liver Disease just ended after two great days of learning and networking in Utrecht, the Netherlands! 🔥
Participants came together for hands-on training, expert insights, and collaborative problem-solving around cutting-edge spatial omics technologies in liver research.
From Hyperion, CosMx/GeoMx and MALDI imaging to the Spatial Liver Biology Hackathon, this EASL School offered an inspiring two days of learning, exchange, and innovation.
#LiverTwitter #LiverX
📢#EASLMolecularTumourBoard happening today!
Have you registered yet? 👀
👇👇👇
You can still register for today's DeepDive webinar on the latest updates in the EASL CPGs on the management of hepatocellular carcinoma! The discussion will include diagnostic strategies, selection of candidates for surgery and locoregional therapies, and treatment adaptation according to response to systemic therapy.
📅TODAY, 7 October, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/regi…
🎙️Discover the New #TalkLiverToMe episode on Resmetirom and Semaglutide as MASH-targeted therapies!
@JHepatology @DebbieShawcros1 @Tacke_lab @gastaldelli_amy @EASOobesity @EASDnews
#LiverX
In this new episode of #TalkLiverToMe, experts discuss the practical use of resmetirom and semaglutide, based on the 2026 EASL–EASD–EASO Guidance.
Who should be treated, when should therapy start, and how should response be monitored?
Listen on EASL Campus: easlcampus.eu/tltm/episode-1…
Also on Spotify: open.spotify.com/episode/4Wt…
and Apple Podcasts: podcasts.apple.com/ch/podcas…
What if the future of hepatology is not just about treating liver disease, but preventing it before it starts?
Liver health is shaped by far more than what happens in the clinic. Alcohol, nutrition, metabolic health, socioeconomic inequalities, stigma, commercial influences and public policy all play a role in who develops liver disease, and who gets diagnosed in time.
That's why preventive hepatology matters. But the question many clinicians ask us is: what can I actually do about that from my clinic?
🎯 The new EASL Preventive Hepatology Course sets out to answer exactly that. Built on the roadmap of the EASL–Lancet Commission 2.0, it gives hepatologists and allied health professionals:
→ The latest evidence on social and commercial determinants as drivers of liver disease
→ A clear view of which policies genuinely work, and which don't
→ Practical tools to bring prevention and early detection into everyday practice
→ A way into advocacy, for those who want to go further and get involved
Clinicians are among the most trusted voices in health policy. This free course is about helping that voice carry further.
👉 Module 1 is open now: easlcampus.eu/course/prevent…
Prevention starts with knowledge. Let's put it at the heart of liver health.
#Hepatology #PreventiveHepatology #LiverHealth #PublicHealth #EASL
🚨Deadline extended 🚨
The deadline for the #EASLSchools 2027 has been extended to 5 October!
Fine-tune your application and take your pick from 4 exciting Schools across Europe.
🔗easl.eu/what-we-do/education…
@FrancqueSven @MattiasMandorf1 @IvaKosuta @manna_555 @ChokshiLab @docberza @VirginiaHdezGea @ReibergerThomas
#LiverX
The deadline for the EASL Schools 2027 has been extended! Time to fine tune your applications and submit them on 5 October!
🔗 easl.eu/what-we-do/education…
EASL Education retweeted
🆕 EASL-EASD-EASO guidance on resmetirom and semaglutide as #MASH-targeted therapy
💉#Semaglutide: preferred in patients with obesity, T2D or high cardiovascular risk
💊#Resmetirom: prioritised in those without obesity or unable to use GLP-1RAs
🔗bit.ly/4ynVQpR
💡The next episode of #TalkLiverToMe explores how resmetirom and semaglutide may be used in MASH, following the recently published EASL–EASD–EASO guidance.
🔗journal-of-hepatology.eu/art…
More info below
👇
@Jhepatology @DebbieShawcros1 @Tacke_Lab
@gastaldelli_amy @EASOobesity @EASDnews
#LiverX #Resmetirom #Semaglutide
Resmetirom and semaglutide are changing the treatment landscape for MASH, but how should they be used in practice?🤔
Tune in to #TalkLiverToMe this Wednesday for a practical discussion on treatment initiation, monitoring, and efficacy assessment, based on the 2026 EASL–EASD–EASO Guidance.
Read more: easl.eu/event/resmetirom-and…
EASL Education retweeted
You can still apply to the EASL School on #PortalHypertension hosted in #Vienna
in September 23-24 in 2027
@BavenoCoop @EASLnews @AASLDtweets
--> easl.eu/event/portal-hyperte…
📢Explore the key updates from the EASL HCC Clinical Practice Guidelines with the next #EASLDeepDive!
From optimising HCC diagnosis to selecting candidates for surgery and locoregional therapies and adapting management according to systemic treatment response
📰Read the guidelines
journal-of-hepatology.eu/art…
More information and registration below.
👇
@JHepatology @FrancqueSven @jargemib @maximeronot @ma5RN
#LiverX #HCC
Join our next EASL DeepDive to examine key updates from the EASL Clinical Practice Guidelines, including diagnostic strategies, selection of candidates for surgery and locoregional therapies, and treatment adaptation according to response to systemic therapy.
📅7 October, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/regi…
Last week, Module 5 of the EASL MASLD Guidelines Academy took place in Pamplona, Spain. The event brought together 21 nurses, allied health professionals and hepatologists for two days of learning, collaboration and discussion on the implementation of the MASLD Guidelines.
#LiverTwitter #LiverX
Less than a week left to apply to one of the 2027 EASL Schools! Next year, we're excited to be hosting the following opportunities:
• Infections in advanced chronic liver diseases, 4-5 June 2027, Zagreb (Croatia)
• Challenges in the treatment of hepatocellular carcinoma, 25-26 June 2027, Madrid (Spain)
• EASL Bootcamp: bridging the gap between science & medicine in hepatology, 16-18 September 2027 Rotterdam (the Netherlands)
• Portal Hypertension, 23-24 September 2027, Vienna (Austria)
Choose wisely and submit your application by Monday 28 September, 23:59 CEST!
🔗 easl.eu/events/easl-courses-…
🌍 EASL was proud to take part in the 9th Conference on Liver Disease in Africa (COLDA), held on 17-19 September 2026 in Addis Ababa, Ethiopia.
EASL Secretary General Prof. Debbie Shawcross, Prof. Francesco Paolo Russo and Prof. Sabela Lens joined colleagues from across Africa and the international hepatology community for three days of scientific exchange and collaboration.
#COLDA2026 provided an important platform for clinicians, researchers, policymakers and healthcare professionals to share knowledge and discuss the latest developments in the prevention, diagnosis and treatment of liver disease, with a particular focus on the African context.
A warm thank you to SOLDA, the COLDA organisers, speakers, participants and the wider community for an inspiring meeting and for continuing to strengthen collaboration and liver health across Africa.
**
🎙️ We continue the discussions at COLDA with the latest episode of EASL’s Talk Liver To Me podcast, dedicated to the burden of liver disease across Africa.
Hosted by Debbie Shawcross, with guests Wendy Spearman (University of Cape Town), Kwame Asomoah (University of Ghana Business School), the episode explores the evolving epidemiology of liver disease across the continent, including viral hepatitis, MASLD and HCC, as well as priorities for prevention, early detection and equitable access to care.
🎧 Listen to Episode 17, “Africa’s Liver Crisis: Why Is No One Talking About It?”: easlcampus.eu/tltm/episode-1…
@DebbieShawcros1 @SaSi_Lens @fprusso73 @wendy_spearman @EASLedu
✨The EASL MASLD Guidelines Academy 2026 starts today!
26 participants from 20 countries have come together in Angers for Module 1: The basics of MASLD, kicking off a five-module learning journey.
Over the next two days, they’ll explore everything from pathophysiology and epidemiology to screening, non-invasive tests and hands-on liver elastography.
The first step in a programme designed to turn the latest #MASLD guidance into practical clinical knowledge and skills.
Welcome to all our participants and faculty! 👏
ℹ️easl.eu/easl-masld-guideline…
#LiverX
🤝 Module 5 of the EASL MASLD Guidelines Academy has begun in Pamplona!
21 nurses, allied health professionals and hepatologists have come together for two days of interactive, practice-focused learning.
Through clinical cases, role-play and hands-on training, they’ll explore how multidisciplinary care can strengthen patient-centred #MASLD management.
ℹ️easl.eu/event/easl-masld-gui…
#LiverX #MASLDacademy
@ClinicaNavarra @FrancqueSven @rabataller






























